AI system for detecting chronic gut diseases
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests an AI system to help detect and describe chronic diseases of the small intestine. If you are an adult having a small bowel endoscopy or capsule endoscopy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be having a procedure to look inside your small intestine (either endoscopy or capsule endoscopy).
- You must be able to give your permission to take part (informed consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial intelligence (AI) system can help doctors find signs of Crohn's disease better than standard reading of capsule endoscopy images. It is for people who have symptoms that might be Crohn's but whose colonoscopy didn't clearly show the problem.
This study looks at how well a computer “AI” system can help doctors spot stomach and bowel abnormalities during endoscopy (camera tests of the gut). If you’re having a gastroscopy or colonoscopy for symptoms or follow-up care, this could improve how findings are recognized.
This trial tests if an artificial intelligence program can help doctors better detect certain pre-cancerous changes in the stomach lining during an advanced endoscopy procedure. It may benefit people at average risk who are already scheduled for this type of exam.
This pilot study uses a special AI-powered camera and a safe fluorescent dye during your scheduled colonoscopy to map how much fluid leaks through your gut lining. The goal is to better understand gut barrier damage in inflammatory bowel disease and help doctors assess disease severity.
This study tests a new artificial intelligence system designed to help doctors diagnose and manage inflammatory bowel disease (IBD) more effectively. Researchers will compare the system's recommendations with standard care to see if it improves patient outcomes.
This trial uses artificial intelligence to combine CT/MR scans and colonoscopy images to better diagnose and predict outcomes for people with inflammatory bowel disease, intestinal tuberculosis, or Behçet's disease. It aims to see if AI can help doctors make more accurate decisions.
Hear when a new Celiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.